Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

Similar articles for PubMed (Select 17918468)

1.

Advances in the diagnosis and treatment of osteoporosis.

Simmons J, Zeitler P, Steelman J.

Adv Pediatr. 2007;54:85-114. Review.

PMID:
17918468
2.

[The influence of bisphosphonates on fracture healing].

Seebach C, Kurth A, Marzi I.

Orthopade. 2007 Feb;36(2):136-40. Review. German.

PMID:
17242960
3.

Advances in the medical management of osteoporosis.

Kates SL, Kates OS, Mendelson DA.

Injury. 2007 Sep;38 Suppl 3:S17-23. Review.

PMID:
17723788
4.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

5.

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis.

Brumsen C, Hamdy NA, Papapoulos SE.

Medicine (Baltimore). 1997 Jul;76(4):266-83. Review.

PMID:
9279333
6.

[Guidelines for the management of osteoporosis].

Pfeilschifter J.

Internist (Berl). 2008 Oct;49(10):1178, 1180-2, 1184-5. doi: 10.1007/s00108-008-2115-y. German.

PMID:
18704351
7.

Underdiagnosis and under-treatment of osteoporosis following fragility fracture.

Aboyoussef M, Vierkoetter KR.

Hawaii Med J. 2007 Jul;66(7):185-7.

PMID:
17879856
8.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
9.

[Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].

Semler O, Land C, Schönau E.

Orthopade. 2007 Feb;36(2):146-51. German.

PMID:
17252257
10.

Non-response to osteoporosis treatment.

Francis RM.

J Br Menopause Soc. 2004 Jun;10(2):76-80. Review.

PMID:
15207030
11.

The American Orthopaedic Association's "own the bone" initiative to prevent secondary fractures.

Tosi LL, Gliklich R, Kannan K, Koval KJ.

J Bone Joint Surg Am. 2008 Jan;90(1):163-73. doi: 10.2106/JBJS.G.00682.

PMID:
18171971
12.

Use of bisphosphonate therapy for osteoporosis in childhood and adolescence.

Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M.

J Paediatr Child Health. 2003 Mar;39(2):88-92. Review.

PMID:
12603794
13.

Risks and benefits of long-term bisphosphonate therapy.

Schmidt GA, Horner KE, McDanel DL, Ross MB, Moores KG.

Am J Health Syst Pharm. 2010 Jun 15;67(12):994-1001. doi: 10.2146/ajhp090506.

PMID:
20516469
14.

Evaluation of calcium and vitamin D supplementation in bisphosphonate therapy.

Rush DN, Jones MW, Futrell DP, Futrell WR, McDowell JO, Ferreri SP.

J Am Pharm Assoc (2003). 2007 Nov-Dec;47(6):725-8.

PMID:
18032135
15.

Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.

Cramer JA, Silverman S.

Am J Med. 2006 Apr;119(4 Suppl 1):S12-7. Review.

PMID:
16563936
16.

Practical guidance for the management of aromatase inhibitor-associated bone loss.

Hadji P, Body JJ, Aapro MS, Brufsky A, Coleman RE, Guise T, Lipton A, Tubiana-Hulin M.

Ann Oncol. 2008 Aug;19(8):1407-16. doi: 10.1093/annonc/mdn164. Epub 2008 Apr 29.

17.

Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.

Sebba AI.

Clin Ther. 2008 Mar;30(3):443-52. doi: 10.1016/j.clinthera.2008.03.008. Review. Erratum in: Clin Ther. 2008 Jun;30(6):1177-8.

PMID:
18405784
18.
19.

Osteoporosis.

Tuck SP, Francis RM.

Postgrad Med J. 2002 Sep;78(923):526-32. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk